Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
British Journal of Clinical Pharmacology|August 6, 2021
Body weight gain in clozapine-treated patients: Is norclozapine the culprit?Naomi T Jessurun, Hieronymus J Derijks, Rob J van Marum, et al.
Clinical Pharmacology and Therapeutics|June 1, 2025
Exploring the Association Between Intra-Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma PatientsAmy Rieborn, Eline L Giraud, Teun van Gelder, et al.
Cancers|June 10, 2023
Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?Eline L Giraud, Loek A W de Jong, Erik van den Hombergh, et al.
British Journal of Clinical Pharmacology|September 30, 2023
Results of the first international quality control programme for oral targeted oncolyticsEline L Giraud, Lindsey M H Te Brake, Erik C A van den Hombergh, et al.
Expert Opinion on Drug Safety|September 29, 2020
Frequency of real-world reported adverse drug reactions in rheumatoid arthritis patientsEline L Giraud, Naomi T Jessurun, Florence P A M van Hunsel, et al.
The Lancet. Oncology|September 2, 2022
The QT interval prolongation potential of anticancer and supportive drugs: a comprehensive overviewEline L Giraud, Kaylee R M Ferrier, Nienke A G Lankheet, et al.
British Journal of Clinical Pharmacology|August 6, 2024
Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancerEline L Giraud, Stefanie D Krens, Stefan Böhringer, et al.
Drug Safety|February 4, 2021
Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM RegistryEline L Giraud, Pepijn W A Thomas, Jette A van Lint, et al.
Clinical Pharmacokinetics|September 27, 2024
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model EnsemblingBram C Agema, Tolra Kocher, Ayşenur B Öztürk, et al.
Cancer Chemotherapy and Pharmacology|January 17, 2025
Pharmacokinetic exposure and treatment outcomes of lenvatinib in patients with renal cell carcinoma and differentiated thyroid carcinomaMarinda Meertens, Eline L Giraud, Esbar Hassan, et al.
Pageof 2